Health
Inhaled CRISPR Treatment Targets Influenza and SARS-CoV-2 Infections – Genetic Engineering & Biotechnology News
The treatment uses a type of CRISPR to target viral RNA and appears to stop replication of both viruses in the lungs.
If you think breathing in gene editing enzymes to treat infectious diseases, such as the flu or COVID-19, is a technology that is far-fetched or a long way off, think again. A team of investigators from the Georgia Institute of Technology and Emory University has developed a CRISPR-based treatment to stop the replication of both the flu virus and the virus that causes COVID-19 in mice. Moreover, the new treatment is delivered to the lungs via a nebulizer, which could make it simple for patients…
-
General12 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News22 hours agoRainbow Beach surfer’s untold 7/7 story
-
Noosa News12 hours agoWoman airlifted to Brisbane hospital after big cat mauling at south-east Queensland zoo near Toowoomba
-
Noosa News12 hours agoUnvaccinated horse dies from Hendra virus as Queensland records first case in three years